| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |